Patent details

EP3348553 Title: CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR

Basic Information

Publication number:
EP3348553
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP181574351
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
French Title of Invention:
FORMES CRISTALLINES D'UN MODULATEUR DE RÉCEPTEUR D'ANDROGÈNE
German Title of Invention:
KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS
SPC Number:

Dates

Filing date:
04/06/2013
Grant date:
08/07/2020
EP Publication Date:
18/07/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/07/2020
EP B1 Publication Date:
08/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/06/2033
Renunciation date:
Revocation date:
16/05/2024
Annulment date:

Owner

From:
01/07/2020
 
 

Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, United States (US)

Name:
Sloan-Kettering Institute for Cancer Research
Address:
1275 York Avenue, New York, NY 10065, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/07/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HERBERT, Mark R.
Address:
United States (US)

2

Name:
DILHAS, Anna
Address:
Switzerland (CH)

3

Name:
SMITH, Nicholas D.
Address:
United States (US)

4

Name:
OUERFELLI, Ouathek
Address:
United States (US)

Priority

Priority Number:
201261656888 P
Priority Date:
07/06/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4184; A61K 31/4439; A61P 35/00; C07D 401/04;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2024/11
Publication date:
16/09/2024
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
202028
Publication date:
08/07/2020
Description:
Grant (B1)

2

Issue number:
202119
Publication date:
12/05/2021
Description:
Opposition procedure started

3

Issue number:
202436
Publication date:
04/09/2024
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/05/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
15/07/2020 Outgoing Correspondence 1
09/07/2020 Power Of Attorney 1